NSTEMI v1.0
Research type
Research Study
Full title
Non-ST-segment elevation myocardial infarction Registry
IRAS ID
261605
Contact name
Chris P. Gale
Contact email
Sponsor organisation
European Society of Cardiology
Duration of Study in the UK
1 years, 0 months, 1 days
Research summary
Non-ST-segment elevation myocardial infarction (NSTEMI) is a global health and economic burden. NSTEMI is a leading cause of emergency hospitalisation. The incidence of NSTEMI, is increasing with the ageing and co-morbid population. Moreover, the burden and variation of NSTEMI care and outcomes persists despite substantial improvements in its treatment.
It is an international, prospective, longitudinal, multi-centre, international observational study to improve the clinical outcomes of patients hospitalised with NSTEMI, through the identification and reporting of sub-optimal delivery of guideline- indicated care. The study is sponsored by the ESC. Data will be collected from patient source document (patient chart) after patient's consent to do so.
The registry population will comprise consecutive in-patients with ST-segment elevation myocardial infarction presenting in participating countries.
During a 2 weeks recruitment period, each participating centre will consecutively enrolled all consenting patients who meet the eligibility criteria, without any limit to the maximum number of patients included.
A 30-days follow-up assessment will be made based on patient-chart, or remotely by phone or during a patient visit.REC name
HSC REC A
REC reference
19/NI/0122
Date of REC Opinion
18 Jun 2019
REC opinion
Further Information Favourable Opinion